{
    "organizations": [],
    "uuid": "936702edcac0c2644ac2e4094868fa22a5dc1846",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-aduro-announces-milestone-achieved/brief-aduro-announces-milestone-achieved-under-merck-collaboration-idUSASB0C8UV",
    "ord_in_thread": 0,
    "title": "BRIEF-Aduro Announces Milestone Achieved Under Merck Collaboration",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 5 (Reuters) - Aduro Biotech Inc:\n* ADURO ANNOUNCES MILESTONE ACHIEVED UNDER MERCK COLLABORATION FOR INITIATION OF ANTI-CD27 PHASE I TRIAL IN ADVANCED SOLID TUMORS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-06T05:21:00.000+02:00",
    "crawled": "2018-03-06T22:25:35.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "aduro",
        "biotech",
        "inc",
        "aduro",
        "announces",
        "milestone",
        "achieved",
        "merck",
        "collaboration",
        "initiation",
        "phase",
        "trial",
        "advanced",
        "solid",
        "tumor",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}